Astellas Pharma (United States)

1.4k papers and 34.6k indexed citations

About

In recent decades, authors affiliated with Astellas Pharma (United States) have published 1.4k papers, which have received a total of 34.6k indexed citations. Scholars at this organization have produced 332 papers in Pulmonary and Respiratory Medicine, 253 papers in Epidemiology and 250 papers in Oncology on the topics of Prostate Cancer Treatment and Research (183 papers), Antifungal resistance and susceptibility (138 papers) and Urinary Bladder and Prostate Research (123 papers). Their work is cited by papers focused on Epidemiology (7.9k citations), Pulmonary and Respiratory Medicine (7.9k citations) and Infectious Diseases (6.7k citations). Authors at Astellas Pharma (United States) collaborate with scholars in United States, Japan and United Kingdom and have published in prestigious journals including New England Journal of Medicine, The Lancet and Journal of Clinical Oncology. Some of Astellas Pharma (United States)'s most productive authors include Peter L. Bonate, Laura Kovanda, Nkechi Azie, Daniel P. Petrylak, M. Roy First, James Spalding, James J. Keirns, Neal D. Shore, Donald N. Buell and Nancy Martin.

In The Last Decade

Astellas Pharma (United States)

1.3k papers receiving 34.1k citations

Fields of papers published by authors at Astellas Pharma (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Astellas Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Astellas Pharma (United States) at the time of their publication.

Countries citing scholars working at Astellas Pharma (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Astellas Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Astellas Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astellas Pharma (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026